DC
Diag Capital Management, LP
Sector-focusedDiversified strategyQuality / disciplined sizing
Total reported value
$87.4M
Reporting period: 2018-12-31 · Number of holdings: 41
Diag Capital Management, LP disclosed 41 holdings in its latest 13F filing for the period ending 2018-12-31, with total reported value of $87.4M and a quarterly turnover rate of 0.0%.
Personality snowflake
- Concentration
- 15.05
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 100
- Diversification
- 80
- Sizing Uniformity
- 92.8
Recent moves
No holding changes this quarter
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
Showing top 40 holdings (of 41 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BAX | Baxter International INC | Stock-Healthcare | 6.47% | — | — | — |
| 2 | ATNXEUR | Athenex INC | Stock-Other | 6.23% | — | — | — |
| 3 | ZBH | Zimmer Biomet Holdings INC | Stock-Healthcare | 5.66% | — | — | — |
| 4 | ABBV | Abbvie INC | Stock-Healthcare | 5.32% | — | — | — |
| 5 | INCY | Incyte CORP | Stock-Healthcare | 5.25% | — | — | — |
| 6 | QTRX | Quanterix CORP | Stock-Other | 4.69% | — | — | — |
| 7 | CELG | Celgene CORP | Stock-Other | 4.63% | — | — | — |
| 8 | AMGN | Amgen INC | Stock-Healthcare | 4.48% | — | — | — |
| 9 | MDT | Medtronic plc | Stock-Healthcare | 3.76% | — | — | — |
| 10 | ✓ | Quotient LTD | Stock-Other | 3.69% | — | — | — |
| 11 | PCRX 3.25 02-01-19 | Pacira Pharmaceuticals | Stock-Other | 3.67% | — | — | — |
| 12 | TAK | Takeda Pharmaceutic-sp Adr | Stock-Healthcare | 3.41% | — | — | — |
| 13 | ABT | Abbott Laboratories | Stock-Healthcare | 3.19% | — | — | — |
| 14 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 3.19% | — | — | — |
| 15 | ✓ | Mylan N V | Stock-Other | 3.12% | — | — | — |
| 16 | COOL1EUR | Polarityte INC | Stock-Other | 2.82% | — | — | — |
| 17 | VRAYQ | Viewray INC | Stock-Other | 2.76% | — | — | — |
| 18 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 2.47% | — | — | — |
| 19 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 2.46% | — | — | — |
| 20 | AKRXEUR | Akorn INC | Stock-Other | 2.46% | — | — | — |
| 21 | HAE | Haemonetics Corp/mass | Stock-Other | 2.43% | — | — | — |
| 22 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.84% | — | — | — |
| 23 | BHVN | Biohaven Ltd. | Stock-Other | 1.62% | — | — | — |
| 24 | MMSI | Merit Medical Systems INC | Stock-Healthcare | 1.60% | — | — | — |
| 25 | SNY | Sanofi-adr | Stock-Healthcare | 1.50% | — | — | — |
| 26 | GWPH | Gw Pharmaceuticals LTD | Stock-Other | 1.50% | — | — | — |
| 27 | LIVN | LivaNova PLC | Stock-Other | 1.25% | — | — | — |
| 28 | ✓ | Molecular Templates Inc | Stock-Other | 1.13% | — | — | — |
| 29 | ✓ | Foamix Pharmaceuticals LTD | Stock-Other | 1.10% | — | — | — |
| 30 | ✓ | Verrica Pharmaceuticals INC | Stock-Other | 1.07% | — | — | — |
| 31 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 1.00% | — | — | — |
| 32 | XRAY | Dentsply Sirona INC | Stock-Healthcare | 0.87% | — | — | — |
| 33 | AXNX* | Axonics INC | Stock-Other | 0.80% | — | — | — |
| 34 | ✓ | Arya Sciences Acquisition Co | Stock-Other | 0.60% | — | — | — |
| 35 | ADMA | Adma Biologics INC | Stock-Healthcare | 0.50% | — | — | — |
| 36 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 0.37% | — | — | — |
| 37 | ARVN | Arvinas INC | Stock-Other | 0.36% | — | — | — |
| 38 | NVAX 3.75 02-01-23 | Novavax INC | Stock-Healthcare | 0.33% | — | — | — |
| 39 | NEOS | Neos Therapeutics INC | Stock-Other | 0.32% | — | — | — |
| 40 | ANAB | Anaptysbio INC | Stock-Other | 0.11% | — | — | — |
Reported value over time
Not enough data yet to compute personality scores
Sector allocation
Sector allocation over time
Not enough sector-mapped data yet
Quarterly history
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
FAQ
What is Diag Capital Management, LP and what type of investor is it?
Diag Capital Management, LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2018-12-31), the firm manages a tracked equity portfolio valued at approximately $87.4M, spread across 41 disclosed positions.
What are Diag Capital Management, LP's largest equity positions?
Based on the latest 13F filing, Diag Capital Management, LP's top holdings by market value are:
1. Baxter International INC (BAX) — $5.7M (6.5%)
2. Athenex INC (ATNXEUR) — $5.4M (6.2%)
3. Zimmer Biomet Holdings INC (ZBH) — $4.9M (5.7%)
4. Abbvie INC (ABBV) — $4.6M (5.3%)
5. Incyte CORP (INCY) — $4.6M (5.3%)
What changes did Diag Capital Management, LP make in its most recent portfolio filing?
No notable portfolio changes were recorded for Diag Capital Management, LP in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Diag Capital Management, LP focus on?
Diag Capital Management, LP is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%